Research Article
Asymptomatic Hyperamylasemia in Stevens-Johnson Syndrome Is Associated with Intestinal Barrier Dysfunction
Table 2
General patient characteristics.
| | Global population () | Patient | Gender | Age | Amylase | Lipase | BG | ALT | AST | FOBT |
| Gender Male/female | 6 (66.7%)/3 (33.3%) | 1 | M | 20 | 663 | 555.5 | 7 | 82 | 50 | +++ | Age | | 2 | M | 26 | 479 | 862.2 | 3.9 | 17 | 15 | + | Amylase | | 3 | M | 59 | 218 | – | 5.9 | 51 | 39 | + | Lipase | | 4 | F | 49 | 168 | – | 5.6 | 17 | 11 | ± | BG | | 5 | F | 51 | 140 | 31 | 7.2 | 13 | 12 | - | ALT | | 6 | M | 24 | 132 | 56.6 | 4.8 | 270 | 36 | - | AST | | 7 | M | 28 | 103 | 57.5 | 4.8 | 101 | 34 | - | FOBT Positive/negative | 5 (55.6%)/4 (44.4%) | 8 | F | 27 | 79 | 85.2 | 5.3 | 30 | 24 | + | 9 | M | 60 | 77 | 29.9 | 5 | 26 | 11 | - |
|
|